17701005

Source:http://linkedlifedata.com/resource/pubmed/id/17701005

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008838, umls-concept:C0030705, umls-concept:C0031928, umls-concept:C0032790, umls-concept:C0045093, umls-concept:C0087111, umls-concept:C0231175, umls-concept:C0346647, umls-concept:C0442027, umls-concept:C0596581, umls-concept:C0879262
pubmed:issue	4
pubmed:dateCreated	2007-8-16
pubmed:abstractText	This study set out to evaluate, in patients with gemcitabine-resistant pancreatic cancer, the response rate and toxicity of S-1 plus cisplatin (CDDP).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9616295
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid, http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination), http://linkedlifedata.com/resource/pubmed/chemical/Tegafur, http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1341-9625
pubmed:author	pubmed-author:ItoHiroshiH, pubmed-author:KatoAtsushiA, pubmed-author:KimuraFumioF, pubmed-author:MiyazakiMasaruM, pubmed-author:OhtsukaMasayukiM, pubmed-author:SawadaShigeakiS, pubmed-author:ShimizuHiroakiH, pubmed-author:TogawaAkiraA, pubmed-author:YoshidomeHiroyukiH, pubmed-author:YoshitomiHideyukiH
pubmed:issnType	Print
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	268-73
pubmed:meshHeading	pubmed-meshheading:17701005-Administration, Oral, pubmed-meshheading:17701005-Aged, pubmed-meshheading:17701005-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17701005-Cisplatin, pubmed-meshheading:17701005-Deoxycytidine, pubmed-meshheading:17701005-Drug Combinations, pubmed-meshheading:17701005-Drug Resistance, Neoplasm, pubmed-meshheading:17701005-Female, pubmed-meshheading:17701005-Humans, pubmed-meshheading:17701005-Male, pubmed-meshheading:17701005-Middle Aged, pubmed-meshheading:17701005-Oxonic Acid, pubmed-meshheading:17701005-Pancreatic Neoplasms, pubmed-meshheading:17701005-Pilot Projects, pubmed-meshheading:17701005-Survival Analysis, pubmed-meshheading:17701005-Tegafur, pubmed-meshheading:17701005-Treatment Failure, pubmed-meshheading:17701005-Treatment Outcome
pubmed:year	2007
pubmed:articleTitle	Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study.
pubmed:affiliation	Department of General Surgery, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba, 260-0856, Japan.
pubmed:publicationType	Journal Article, Clinical Trial